Your browser doesn't support javascript.
loading
A tailored approach to reduce dose of anti-TNF drugs may be equally effective, but substantially less costly than standard dosing in patients with ankylosing spondylitis over 1 year: a propensity score-matched cohort study.
Závada, Jakub; Uher, Michal; Sisol, Katarína; Forejtová, Sárka; Jarosová, Katerina; Mann, Herman; Vencovský, Jirí; Pavelka, Karel.
Afiliação
  • Závada J; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Uher M; Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic.
  • Sisol K; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Forejtová S; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Jarosová K; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Mann H; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Vencovský J; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Pavelka K; Institute of Rheumatology and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Ann Rheum Dis ; 75(1): 96-102, 2016 Jan.
Article em En | MEDLINE | ID: mdl-25165033

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Fator de Necrose Tumoral alfa / Antirreumáticos / Quimioterapia de Manutenção Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espondilite Anquilosante / Fator de Necrose Tumoral alfa / Antirreumáticos / Quimioterapia de Manutenção Tipo de estudo: Etiology_studies / Guideline / Health_economic_evaluation / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article